Maturational Intermediates of Trimeric HIV-1 Envelope as Unique Immunogens
Maturational Intermediates of Trimeric HIV-1 Envelope as Unique Immunogens
批准号:
8790245
负责人:
MARK AYER MUESING
金额:
$28.48万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-06-06 至 2016-05-31
关键词:
AdoptionAffinityAmino AcidsAntibodiesAntigensBindingBiochemicalBiologicalBiological AssayBiological PreservationCell membraneCellsCollectionComplexCoupledDNA Sequence RearrangementEndoglycosidasesEndoplasmic ReticulumEngineeringEpitopesEventFundingGenerationsGeneticGlycoproteinsGolgi ApparatusGrowthHIV Envelope Protein gp120HIV InfectionsHIV-1HumanImmunofluorescence ImmunologicImmunoprecipitationInfectionInterruptionLaboratoriesLifeLocationMannoseMapsMasksMass Spectrum AnalysisMeasuresMediatingMembrane FusionMethodologyMethodsModelingMolecularMolecular ChaperonesMolecular Sieve ChromatographyN-terminalNew ZealandOryctolagus cuniculusPathway interactionsPatternPeptidesPolysaccharidesPost-Translational Protein ProcessingProcessProductionPropertyProtein RegionProteinsProteolytic ProcessingProteomeProteomicsRecombinant ProteinsRecombinantsSeriesSolventsSourceSpecific qualifier valueStructureSuspension substanceSuspensionsSystemTechniquesTechnologyTestingTimeTranslationsViralViral Envelope ProteinsViral ProteinsVirionVirusbasecryogenicsenv Gene Productsglycosylationgp160immunogenicimmunogenicitymagnetic beadsneutralizing antibodyprogramsprototypepublic health relevancereceptorrecombinant virusresponsespatiotemporaltransmission processvaccine development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: We have previously developed methodology to engineer the incorporation of a potent, foreign affinity tag (3xFLAG) into the HIV-1 proteome. As these engineered viruses are generated through a process based on viability, the tagged and essential viral protein must remain functional, likely to undergo the same interactions encountered by the wild type virus. Furthermore, because the foreign tag is stably accommodated over several cycles of viral growth, high-level expression and purification of a specific tagged viral protein can be obtained through biological amplification of the recombinant virus. In conjunction with cryogenic preservation of transient viral-host interactions and differential isotopic mass spectrometry techniques that can differentiate specific from nonspecific protein interactions, unequivocal identification of host complexes that specifically interact with the viral machinery during progressive infection has been made possible.
In this proposal, we focus on another powerful attribute of our epitope-tagged viruses-the potential for selective and quantitative purification of maturational intermediates of a given vira protein directly from infected cells. Our focus here is the viral envelope protein (Env), arguably the most structurally and biochemically diversified protein of the virus and as the only solvent exposed protein of the virion, the most relevant target for vaccine development. Remarkably and unpredictably, our prototype Env 3xFLAG-tagged virus, Env-3xF, has provided us with the ability to preferentially recover and purify immature Env derivative(s) from a defined step-soon after its translation in the endoplasmic reticulum-at a point when the protein is neither proteolytically processed nor fully glycosylated but exists as a high-mannose, trimerized derivative of gp160.
Here, we propose a model whereby neutralization-specific epitopes may be exposed at steps along the Env maturation pathway, when extensive glycosylation is limited and chaperone-mediated folding of structural intermediates of the glycoprotein is in progress. In addition to our
prototype Env-3xF virus, we propose to construct and select an additional set of viruses derived from our original TCLA proviral clone as well as a transmitted viral founder clone (CH077) targeting different functional domains of gp120 or gp41 for 3xFLAG tag incorporation. Selective immunopurification of native maturational intermediates of Env may enrich for those rudimentary molecules in which rare, neutralization-sensitive epitopes, masked in the fully mature protein, are exposed and in a proper context to elicit a relevant immunological response. Such a panel of replication competent viruses may offer a wide spectrum of unique biochemical and/or immunological properties. Thus, the modified viruses will be expanded by biological amplification, the Env protein immunopurified and eluted under native conditions and then evaluated for the generation of broadly neutralizing antibodies in rabbits.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HOST INTERACTIONS OF GENE PRODUCTS FROM HIV-1
-
批准号:8361508
-
项目类别:
-
资助金额:$6.72万
-
财政年份:2011
-
负责人:MARK AYER MUESING
-
依托单位:
HOST INTERACTIONS OF GENE PRODUCTS FROM HIV-1
-
批准号:8169125
-
项目类别:
-
资助金额:$9.5万
-
财政年份:2010
-
负责人:MARK AYER MUESING
-
依托单位:
Revealing the HIV-1 Interactome
-
批准号:8415922
-
项目类别:
-
资助金额:$42.03万
-
财政年份:2009
-
负责人:MARK AYER MUESING
-
依托单位:
Revealing the HIV-1 Interactome
-
批准号:8016699
-
项目类别:
-
资助金额:$44.72万
-
财政年份:2009
-
负责人:MARK AYER MUESING
-
依托单位:
Revealing the HIV-1 Interactome
-
批准号:8211020
-
项目类别:
-
资助金额:$44.72万
-
财政年份:2009
-
负责人:MARK AYER MUESING
-
依托单位:
Revealing the HIV-1 Interactome
-
批准号:7685768
-
项目类别:
-
资助金额:$45.63万
-
财政年份:2009
-
负责人:MARK AYER MUESING
-
依托单位:
HOST INTERACTIONS OF GENE PRODUCTS FROM HIV-1
-
批准号:7954081
-
项目类别:
-
资助金额:$9.26万
-
财政年份:2009
-
负责人:MARK AYER MUESING
-
依托单位:
Revealing the HIV-1 Interactome
-
批准号:7916902
-
项目类别:
-
资助金额:$24.85万
-
财政年份:2009
-
负责人:MARK AYER MUESING
-
依托单位:
Revealing the HIV-1 Interactome
-
批准号:7766256
-
项目类别:
-
资助金额:$45.17万
-
财政年份:2009
-
负责人:MARK AYER MUESING
-
依托单位:
HIV INTEGRASE SH3 INTERACTIONS
-
批准号:7722234
-
项目类别:
-
资助金额:$0.41万
-
财政年份:2008
-
负责人:MARK AYER MUESING
-
依托单位:
HOST INTERACTIONS OF GENE PRODUCTS FROM HIV-1
-
批准号:7722221
-
项目类别:
-
资助金额:$5.51万
-
财政年份:2008
-
负责人:MARK AYER MUESING
-
依托单位:
HOST INTERACTIONS OF GENE PRODUCTS FROM HIV-1
-
批准号:7355109
-
项目类别:
-
资助金额:$5.52万
-
财政年份:2006
-
负责人:MARK AYER MUESING
-
依托单位:
HIV INTEGRASE SH3 INTERACTIONS
-
批准号:7355128
-
项目类别:
-
资助金额:$0.83万
-
财政年份:2006
-
负责人:MARK AYER MUESING
-
依托单位:
HOST INTERACTIONS OF GENE PRODUCTS FROM HIV-1
-
批准号:7180016
-
项目类别:
-
资助金额:$9.34万
-
财政年份:2005
-
负责人:MARK AYER MUESING
-
依托单位:
A Genetic/Proteomic Approach to Virus-Host Interactions
-
批准号:7006367
-
项目类别:
-
资助金额:$27.0万
-
财政年份:2005
-
负责人:MARK AYER MUESING
-
依托单位:
IDENTIFYING PHOSPHORYLATION SITES OF HIV INTEGRASE BY MASS SPECTROMETRY
-
批准号:7179934
-
项目类别:
-
资助金额:$0.47万
-
财政年份:2005
-
负责人:MARK AYER MUESING
-
依托单位:
A Genetic/Proteomic Approach to Virus-Host Interactions
-
批准号:7140585
-
项目类别:
-
资助金额:$26.37万
-
财政年份:2005
-
负责人:MARK AYER MUESING
-
依托单位:
Inhibition of Integrase-Mediated Viral Nuclear Transport
-
批准号:6843072
-
项目类别:
-
资助金额:$27.31万
-
财政年份:2004
-
负责人:MARK AYER MUESING
-
依托单位:
Inhibition of Integrase-Mediated Viral nuclear Transport
-
批准号:6954149
-
项目类别:
-
资助金额:$27.0万
-
财政年份:2004
-
负责人:MARK AYER MUESING
-
依托单位:
IDENTIFYING PHOSPHORYLATION SITES OF HIV INTEGRASE
-
批准号:6975799
-
项目类别:
-
资助金额:$0.61万
-
财政年份:2004
-
负责人:MARK AYER MUESING
-
依托单位:
海外基金